자궁내막증 치료제 시장 규모는 최근 몇년간 큰 성장률로 급성장하고 있으며, 2021년부터 2028년까지 시장 규모·추계·예측에 있어서도 시장은 크게 성장할 것으로 예측됩니다.
자궁 내막증의 유병률 증가는 자궁 내막증 치료와 관련된 여성의 의식의 향상으로 이어지고 있습니다. 또한 이 시장의 성장 기회가 점점 확대되고 있습니다. 자궁 내막증 치료제 세계 시장 보고서는 시장의 전반적인 평가를 제공합니다.
세계의 자궁내막증 치료제 시장의 정의
자궁내막증은 만성 통증을 동반하는 질환으로, 자궁을 외형적으로 둘러싸는 조직(난관, 난소, 자궁을 지지하는 인대에서 볼 수 있음)이 파열되어 염증이나 내출혈을 일으킵니다. 증상, 유착, 통증, 흉터 조직의 형성, 장관 장애를 일으킬 수 있습니다. 배변통, 성행위시 통증, 생리 전이나 생리 중 통증, 불임증, 생리 중 배뇨통, 피로감, 설사, 메스꺼움, 변비 등의 위장 장애 등이 있습니다. 따라서 질병의 정도, 통증의 정도, 임신 가능성에 따라 관리를위한 의료 전략을 수립하는 것이 중요합니다.
자궁 내막증의 치료에는 통증 치료제, 호르몬 피임약, 황체 호르몬 전용 피임약, gonadotroin 방출 호르몬(GnRH) 아날로그 약물, 아로마타제 억제제 등 다양한 약물이 있습니다. 아로마타제 억제제는 이것을 억제하고 에스트로겐의 수준을 낮춥니다. 이 약물은 자궁 내막증의 치료에 일상적으로 사용되지 않습니다. 자궁 내막증과 관련된 다량의 월경 출혈을 멈출 수 있습니다.
세계의 자궁내막증 치료제 시장 개요
여성의 건강에 대한 관심 증가는 예측기간 동안 자궁내막증 치료제 시장 규모 성장을 뒷받침하는 중요한 요인입니다. 의식 향상을 위해 노력하고 있습니다. 여성의 건강에 대한 관심은 세계 자궁내막증 치료제 시장의 확대로 이어집니다. 시장 성장을 가속하기 위해 적극적으로 기대하고 있습니다.
시장 전체의 성장을 억제하는 일정한 억제요인과 과제가 직면하고 있습니다., 시장 추계·예측 기간 중의 성장을 둔화시킬 것으로 예측되고 있습니다. 인지도가 낮아 시장 성장의 과제가 되고 있습니다. 또한, 이 질환의 진단에 걸리는 시간은 길고, 연구자들은 7-9년으로 추정하고 있습니다. 하이테크 의료기기·장치의 부족과 더불어, 비침습적인 진단 검사는 이용할 수 없습니다. 이것은 세계의 자궁내막증 치료제 시장 전체의 성장을 방해하는 잠재적인 요인입니다.
Endometriosis Drugs Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2021 to 2028.
The growing prevalence of endometriosis has also lead to higher awareness among women related to endometriosis treatment. Moreover, the significant rise in the occurrence of this disease, investment in research, and development are also increasingly expanding growth opportunities in this market. The Global Endometriosis Drugs Market report provides a holistic evaluation of the market. The report offers comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Endometriosis Drugs Market Definition
Endometriosis is a chronic and painful condition, where the tissues that outline the uterus externally (found in the fallopian tubes, ovaries, and ligaments that support the uterus) ruptures and causes inflammation and internal bleeding. This can cause infertility, adhesions, pain, scar tissue formation, and bowel problems. Symptoms of the disease include painful bowel movements during periods, pain with sex, pain before and during periods, infertility, painful urination during periods, fatigue, and other gastrointestinal problems such as diarrhea, nausea, and constipation. Endometriosis is a lifelong condition so it is important to develop a medical strategy to manage it based on the extent of the disease, severity of pain, and potential plans for pregnancy.
There are various medications available to cure endometriosis such as Pain Medication, Hormone Birth Control, Progestin-only contraceptives, Gonadotroin-releasing Hormone (GnRH) Analogues, and Aromatase Inhibitors. Aromatase is a chemical that boosts your body's estrogen production. Aromatase inhibitors block it, which lowers your estrogen level. These medicines aren't routinely used to treat endometriosis. Whereas, hormone birth control can stop the heavy menstrual bleeding that generally accompanies endometriosis.
Global Endometriosis Drugs Market Overview
The growing focus emphasis on women's health is the key factor in boosting the growth of the endometriosis drugs market size during the forecast period. The various governmental authorities and organizations are working to raise awareness to overcome unawareness and uneducated challenges problems. The focus on women's health will lead to the expansion of the global endometriosis drugs market. Moreover, the significant rise in the occurrence of this disease, investment in research, and development has positively anticipated in propelling the growth of the global Endometriosis drugs market.
There are certain restraints and challenges faced which will hinder the overall market growth. The factors such as the endometriosis drug market are dominated by high-cost hormone-based therapeutics, which is a significant concern for patients and is estimated to sluggish growth during the forecast period. Lack of awareness about various gynecological cancer indications such as endometriosis and endometrial cancer was a challenge for the growth of the market. Further, the time that is taken to diagnose the disease is high, which is estimated by the researchers as seven to nine years. Till now, there are no diagnostic tests available that are non-invasive coupled with a lack of medical infrastructure and hi-tech medical equipment and devices. These are the potential restraints hampering the overall growth of the global Endometriosis drugs market.
Global Endometriosis Drugs Market is segmented based on Product, Application, And Geography.
Endometriosis Drugs Market by Product
Based on Product, the market is bifurcated into Hormonal Therapy, Add-back Medication, Progestogens, and Chinese Herbs. The hormone therapy segment holds the largest market share for the forecast period. It is considered the most effective treatment for endometriosis as it can reduce or effectively eliminate the pain associated with the condition compared with analgesics. This factor will increase sales of medications that act on hormones associated with the condition. The sales of hormonal medications will further improve with the introduction of novel drug delivery systems.
Endometriosis Drugs Market by Application
Based on Application, the market is bifurcated into Hospitals, Clinics, Research Institutes. The hospital segment is estimated to witness the highest CAGR for the forecast period. The factors that can be attributed to the growing prevalence of endometriosis and rise in the occurrence of this disease are fueling the demand for this segment.
Endometriosis Drugs Market by Geography
On the basis of regional analysis, the Global Endometriosis Drugs Market is classified into
North America
Europe
Asia Pacific
Rest of the world
North America holds the largest market share. The increasing treatment costs, higher disability losses, and the large number of reproductive populations that are suffering from endometriosis. High awareness among people, strong governmental initiatives and ongoing projects will boost the market in this region.
The market analysis entails a section solely dedicated to major players in the Global Endometriosis Drugs Market wherein our analysts provide an insight into the financial statements of all the major players along with its key developments product benchmarking and SWOT analysis. The company profile section also includes a business overview and financial information. The companies that are provided in this section can be customized according to the client's requirements.
Partnerships, Collaborations and Agreements
Product Launches and Product Expansions